当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析

泓博医药

(301230)

  

流通市值:46.88亿  总市值:52.09亿
流通股本:1.26亿   总股本:1.40亿

泓博医药(301230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.24亿元,每股收益0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益102995.16万元,未分配利润13362.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产131584.34万元,负债28589.18万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入172,285,876.53688,350,863.65514,401,151.54352,738,072.83
营业总成本159,696,084.51655,923,295.42484,120,946.96329,746,732.17
其他经营收益
营业利润26,398,618.3428,621,094.9532,017,358.5122,744,651.53
利润总额25,984,761.8228,316,885.731,825,220.4522,677,172.91
净利润23,779,249.534,294,767.3234,749,579.2624,761,426.27
每股收益
其他综合收益-114,466.4-17,625.94-79,436.07-112,334.74
综合收益总额23,664,783.134,277,141.3834,670,143.1924,649,091.53
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计578,133,505.52582,095,905.67562,877,685.5618,934,271.92
非流动资产:
非流动资产合计737,709,880.14732,003,270.12742,666,439.86737,651,658.01
资产总计1,315,843,385.661,314,099,175.791,305,544,125.361,356,585,929.93
流动负债:
流动负债合计153,754,515.99172,212,045.67138,007,757.07149,623,885.8
非流动负债:
非流动负债合计132,137,306.02137,657,022.3141,353,423.12146,798,435.93
负债合计285,891,822.01309,869,067.97279,361,180.19296,422,321.73
所有者权益(或股东权益):
归属于母公司股东权益合计1,029,951,563.651,004,230,107.821,026,182,945.171,060,163,608.2
股东权益合计1,029,951,563.651,004,230,107.821,026,182,945.171,060,163,608.2
负债和股东权益合计1,315,843,385.661,314,099,175.791,305,544,125.361,356,585,929.93
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计176,532,345.46604,871,381.42451,715,185.39281,252,796.67
经营活动现金流出小计146,784,870.1469,359,439.29369,200,872.98241,826,667.93
经营活动产生的现金流量净额29,747,475.36135,511,942.1382,514,312.4139,426,128.74
投资活动产生的现金流量:
投资活动现金流入小计167,625,628.1223,226,822.5320,105,380.5320,105,380.53
投资活动现金流出小计172,118,035.7866,616,262.0153,694,584.7127,276,315.2
投资活动产生的现金流量净额-4,492,407.66-43,389,439.48-33,589,204.18-7,170,934.67
筹资活动产生的现金流量:
筹资活动现金流入小计-25,664,755.5825,664,755.5820,664,755.58
筹资活动现金流出小计19,808,244.53105,533,456.1681,683,294.5123,924,858.9
筹资活动产生的现金流量净额-19,808,244.53-79,868,700.58-56,018,538.93-3,260,103.32
汇率变动对现金及现金等价物的影响-1,553,587.611,815,915.652,251,028.462,110,728
现金及现金等价物净增加额3,893,235.5614,069,717.72-4,842,402.2431,105,818.75
期末现金及现金等价物余额56,711,900.4552,818,664.8933,906,544.9369,854,765.92
补充资料:
现金及现金等价物的净增加额-14,069,717.72-31,105,818.75
TOP↑